TriNetX has acquired Zetta Genomics assets, aiming to expand its genomics data management and analytics capabilities for healthcare providers and life science researchers. The move is intended to strengthen how users can access and analyze genomic information alongside clinical records within the TriNetX ecosystem. With Zetta’s XetaBase platform, TriNetX expects to improve data handling and computational workflows that support research use cases, including retrospective analyses and trial-related recruitment insights. The acquisition also signals sustained consolidation in health data infrastructure, where platform capabilities around genomics ingestion, normalization and analytics are increasingly seen as differentiators. For biotech stakeholders, the practical impact will be whether the combined platform accelerates access to large-scale genomic cohorts and improves compatibility with clinical study workflows.